Skip to content
Spin Daily

Administering Stem Cells During Pregnancy to Infants with Neural Tube Defect Boosts Life Outcomes, Trial Finds

An innovative medical trial has found that administering stem cells to developing infants diagnosed with spina bifida while undergoing fetal surgery could constitute a "significant breakthrough" in managing prenatal disorders.

Trial Details and Safety

The US-based trial focused on six developing infants with the 'open' form of spina bifida. Doctors administered mother's placental stem cells to the surface of the infant's spine as part of the surgical correction.

Critically, the stem cell application was found to be safe. The study team reported that the therapy did not induce neoplasms, interfere with wound healing, or impede the resolution of related neurological issues.

Encouraging Results

Imaging conducted after delivery showed a complete reversal of brainstem displacement in each of the babies. This brain structure normalization is closely linked to enhanced physical outcomes.

"In the event it allows additional babies to achieve ambulation who wouldn't have, it may emerge as the conventional approach," said the lead researcher. "The outcomes appear extremely promising and create a pathway toward a variety of prospective novel therapies."

Broader Impact and Encouragement

Experts not involved in the trial have suggested that additional validation of these noted improvements could announce a "new era" in in-utero treatment. The possibility of ameliorating neural deficits occurring during fetal development is considered a revolutionary objective.

Notably important would be improvements in bladder and bowel function, which are common challenges for those diagnosed with this disorder.

Future Directions

While this initial trial was small in scale, its safety demonstration and positive signals provide a strong foundation for larger, more comprehensive studies. The integration of stem cell therapy with established fetal surgery techniques holds considerable promise for transforming outcomes for babies yet to be born with spina bifida.

By

Melissa Blake

A tech journalist with over 8 years of experience covering emerging technologies and digital innovations across Europe.

Spin Daily

Type to search articles.